12885_2016_2162_MOESM3_ESM.pdf (256.31 kB)
Additional file 3: of The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts
journal contribution
posted on 2016-03-02, 05:00 authored by Melanie Mediavilla-Varela, Kingsley Boateng, David Noyes, Scott AntoniaMTS assay showing the viability of A549 cells after 72-h treatment with a low dose of cisplatin (Cis; 10 μM) and low dose of pirfenidone (Pirf; 0.5 mg/mL) in the presence and absence of the MEK inhibitor U0126 (U; 10 μM). (PDF 3219 kb)
